Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Novo Nordisk in the Drug Discovery & Development Pharma 50

Novo Nordisk

Rank: 15

2022 Rank: 19

Bagsværd, Denmark
www.novonordisk.com

2022 Revenues ($USD) : $24,998,446,020.00
2022 Revenues (foreign currencies) : DKK kr176,954,000,000
2022 R&D spend : $2,713,672,195.00
2022 Number of Employees : 55,185
Fiscal Year End : 12/31/22
Leader : CEO Lars Fruergaard Jørgensen

Novo Nordisk is a global healthcare company headquartered in Bagsværd, Denmark, and specializing in diabetes care. It reported full-year 2022 revenue of DKK 176.954 billion ($24.998 billion), reflecting the company's robust performance throughout the year. Sales drivers include the company's GLP-1 diabetes treatments and its diabetes and obesity care segments. As part of its environmental, social, and governance (ESG) initiatives, Novo Nordisk prioritizes sustainability, diversity, and inclusion. The percentage of women in leadership positions increased from 42% to 44% as of Q4 2022, while women in senior leadership positions grew from 35% to 39% during the same period. The company aims to achieve balanced gender representation across all managerial levels by the end of 2025. —BB
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE